PHAS
State Street’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-91,850
| Closed | -$16K | – | 4971 |
|
|
2022
Q3 | $16K | Hold |
91,850
| – | – | ﹤0.01% | 4857 |
|
|
2022
Q2 | $55K | Buy |
91,850
+4,000
| +5% | +$2.4K | ﹤0.01% | 4706 |
|
|
2022
Q1 | $116K | Buy |
87,850
+8,772
| +11% | +$11.6K | ﹤0.01% | 4600 |
|
|
2021
Q4 | $206K | Hold |
79,078
| – | – | ﹤0.01% | 4336 |
|
|
2021
Q3 | $246K | Hold |
79,078
| – | – | ﹤0.01% | 4284 |
|
|
2021
Q2 | $294K | Sell |
79,078
-265,579
| -77% | -$987K | ﹤0.01% | 4059 |
|
|
2021
Q1 | $1.19M | Buy |
344,657
+66,700
| +24% | +$231K | ﹤0.01% | 3582 |
|
|
2020
Q4 | $934K | Sell |
277,957
-22,800
| -8% | -$76.6K | ﹤0.01% | 3563 |
|
|
2020
Q3 | $1.06M | Buy |
300,757
+42,674
| +17% | +$150K | ﹤0.01% | 3416 |
|
|
2020
Q2 | $1.19M | Buy |
258,083
+8,773
| +4% | +$40.4K | ﹤0.01% | 3373 |
|
|
2020
Q1 | $825K | Buy |
249,310
+19,531
| +8% | +$64.6K | ﹤0.01% | 3351 |
|
|
2019
Q4 | $1.4M | Buy |
229,779
+8,537
| +4% | +$52.2K | ﹤0.01% | 3350 |
|
|
2019
Q3 | $923K | Buy |
221,242
+31,568
| +17% | +$132K | ﹤0.01% | 3415 |
|
|
2019
Q2 | $1.57M | Buy |
+189,674
| New | +$1.57M | ﹤0.01% | 3327 |
|